ES2375624T3 - Microgranulados de liberación controlada y procedimiento para su producción. - Google Patents
Microgranulados de liberación controlada y procedimiento para su producción. Download PDFInfo
- Publication number
- ES2375624T3 ES2375624T3 ES02760617T ES02760617T ES2375624T3 ES 2375624 T3 ES2375624 T3 ES 2375624T3 ES 02760617 T ES02760617 T ES 02760617T ES 02760617 T ES02760617 T ES 02760617T ES 2375624 T3 ES2375624 T3 ES 2375624T3
- Authority
- ES
- Spain
- Prior art keywords
- water
- layer
- release
- film layer
- soluble
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001248426A JP4848101B2 (ja) | 2001-08-17 | 2001-08-17 | 徐放性マイクロペレット |
| JP2001248426 | 2001-08-17 | ||
| PCT/JP2002/008245 WO2003015758A1 (en) | 2001-08-17 | 2002-08-12 | Sustained release micropellets and process for producing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2375624T3 true ES2375624T3 (es) | 2012-03-02 |
Family
ID=19077585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES02760617T Expired - Lifetime ES2375624T3 (es) | 2001-08-17 | 2002-08-12 | Microgranulados de liberación controlada y procedimiento para su producción. |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20040208930A1 (https=) |
| EP (1) | EP1417960B1 (https=) |
| JP (1) | JP4848101B2 (https=) |
| AT (1) | ATE531360T1 (https=) |
| AU (1) | AU2002327085B9 (https=) |
| CA (1) | CA2459472C (https=) |
| DK (1) | DK1417960T3 (https=) |
| ES (1) | ES2375624T3 (https=) |
| WO (1) | WO2003015758A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU764453B2 (en) | 1999-10-29 | 2003-08-21 | Euro-Celtique S.A. | Controlled release hydrocodone formulations |
| US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
| MXPA03003895A (es) | 2000-10-30 | 2003-07-28 | Euro Celtique Sa | Formulaciones de hidrocodona de liberacion controlada. |
| EP1663469A4 (en) * | 2003-09-05 | 2009-01-07 | Univ Massachusetts | AMPHIPHILIC POLYMER CAPSULES AND ASSOCIATED METHODS OF INTERFACIAL ASSEMBLY |
| AU2004312059A1 (en) * | 2003-12-31 | 2005-07-21 | Actavis Group Hf | Atomoxetine formulations |
| MX2007003813A (es) * | 2004-10-01 | 2007-04-24 | Firmenich & Cie | Microcapsulas perfumantes o saborizantes que comprenden un supesor de explosion. |
| JP2008525313A (ja) | 2004-12-27 | 2008-07-17 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗痴呆薬の安定化方法 |
| US20070129402A1 (en) * | 2004-12-27 | 2007-06-07 | Eisai Research Institute | Sustained release formulations |
| KR101213345B1 (ko) * | 2005-04-28 | 2012-12-17 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 항치매약을 함유하는 조성물 |
| US20080069891A1 (en) | 2006-09-15 | 2008-03-20 | Cima Labs, Inc. | Abuse resistant drug formulation |
| US8445018B2 (en) | 2006-09-15 | 2013-05-21 | Cima Labs Inc. | Abuse resistant drug formulation |
| CA2798702A1 (en) | 2010-05-11 | 2011-11-17 | Cima Labs Inc. | Alcoholresistant metoprolol-containing extended-release oral dosage forms |
| WO2023187225A1 (en) * | 2022-04-01 | 2023-10-05 | Amplicon Ab | Alkaline intraoral products |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6058890B2 (ja) * | 1978-10-20 | 1985-12-23 | 東洋醸造株式会社 | 抗生物質細粒剤の製造法およびそれを用いる複粒剤 |
| JPS583510A (ja) * | 1981-06-29 | 1983-01-10 | 住友電気工業株式会社 | 海底ケ−ブル等の埋設機の積卸方法 |
| JPS5835110A (ja) * | 1981-08-28 | 1983-03-01 | Tetsuo Kato | 徐放性マイクロカプセル |
| JPS5944311A (ja) * | 1982-09-07 | 1984-03-12 | Santen Pharmaceut Co Ltd | 徐放性顆粒およびその製造法 |
| US4777049A (en) * | 1983-12-01 | 1988-10-11 | Alza Corporation | Constant release system with pulsed release |
| GB2150434B (en) * | 1983-12-01 | 1987-11-04 | Alza Corp | Constant rate release systems |
| DK62184D0 (da) * | 1984-02-10 | 1984-02-10 | Benzon As Alfred | Diffusionsovertrukket polydepotpraeparat |
| US4753802A (en) * | 1986-03-19 | 1988-06-28 | Alza Corporation | Verapamil dosage form |
| US5026560A (en) * | 1987-01-29 | 1991-06-25 | Takeda Chemical Industries, Ltd. | Spherical granules having core and their production |
| JPH0832625B2 (ja) * | 1987-01-29 | 1996-03-29 | 武田薬品工業株式会社 | 有核顆粒およびその製造法 |
| US4931285A (en) * | 1988-04-28 | 1990-06-05 | Alza Corporation | Aqueous based pharmaceutical coating composition for dosage forms |
| US5202128A (en) * | 1989-01-06 | 1993-04-13 | F. H. Faulding & Co. Limited | Sustained release pharmaceutical composition |
| HU205851B (en) * | 1989-01-31 | 1992-07-28 | Int Pharma Agentur | Systhem of regulated release of the active components and process for producing it |
| JP2820829B2 (ja) * | 1991-03-07 | 1998-11-05 | 武田薬品工業株式会社 | 有核散剤およびその製造方法 |
| US5229135A (en) * | 1991-11-22 | 1993-07-20 | Prographarm Laboratories | Sustained release diltiazem formulation |
| IT1264020B (it) * | 1993-01-28 | 1996-09-09 | Recordati Chem Pharm | Procedimento per la preparazione di microgranuli idonei alla sospensione in liquidi |
| EP0711166A1 (en) * | 1993-07-22 | 1996-05-15 | Warner-Lambert Company | Controlled release tacrine drug delivery systems and methods for preparing same |
| JPH0789849A (ja) * | 1993-09-20 | 1995-04-04 | Fujisawa Pharmaceut Co Ltd | 徐放性製剤 |
| US6077533A (en) * | 1994-05-25 | 2000-06-20 | Purdue Pharma L.P. | Powder-layered oral dosage forms |
| US5411745A (en) * | 1994-05-25 | 1995-05-02 | Euro-Celtique, S.A. | Powder-layered morphine sulfate formulations |
| JPH10139659A (ja) * | 1996-09-10 | 1998-05-26 | Freunt Ind Co Ltd | 球形粒子群、その製造方法及びそれを用いた球形粒子製剤 |
| TW477702B (en) * | 1997-10-23 | 2002-03-01 | Dev Center Biotechnology | Controlled release tacrine dosage form |
| SE9704869D0 (sv) * | 1997-12-22 | 1997-12-22 | Astra Ab | New pharmaceutical formulaton II |
| FR2794646B1 (fr) * | 1999-06-09 | 2001-09-21 | Ethypharm Lab Prod Ethiques | Microgranules de sulfate de morphine, procede de preparation et composition les contenant |
-
2001
- 2001-08-17 JP JP2001248426A patent/JP4848101B2/ja not_active Expired - Lifetime
-
2002
- 2002-08-12 CA CA2459472A patent/CA2459472C/en not_active Expired - Fee Related
- 2002-08-12 EP EP02760617A patent/EP1417960B1/en not_active Expired - Lifetime
- 2002-08-12 WO PCT/JP2002/008245 patent/WO2003015758A1/ja not_active Ceased
- 2002-08-12 US US10/486,898 patent/US20040208930A1/en not_active Abandoned
- 2002-08-12 AU AU2002327085A patent/AU2002327085B9/en not_active Ceased
- 2002-08-12 ES ES02760617T patent/ES2375624T3/es not_active Expired - Lifetime
- 2002-08-12 AT AT02760617T patent/ATE531360T1/de active
- 2002-08-12 DK DK02760617.7T patent/DK1417960T3/da active
-
2007
- 2007-08-16 US US11/889,744 patent/US8512744B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP4848101B2 (ja) | 2011-12-28 |
| CA2459472A1 (en) | 2003-02-27 |
| AU2002327085B9 (en) | 2008-08-14 |
| WO2003015758A1 (en) | 2003-02-27 |
| US20090011034A1 (en) | 2009-01-08 |
| JP2003055199A (ja) | 2003-02-26 |
| EP1417960A4 (en) | 2008-08-13 |
| CA2459472C (en) | 2010-12-14 |
| US20040208930A1 (en) | 2004-10-21 |
| DK1417960T3 (da) | 2012-02-20 |
| EP1417960B1 (en) | 2011-11-02 |
| AU2002327085B2 (en) | 2008-02-14 |
| AU2002327085B8 (en) | 2008-02-28 |
| US8512744B2 (en) | 2013-08-20 |
| EP1417960A1 (en) | 2004-05-12 |
| ATE531360T1 (de) | 2011-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2462536T3 (es) | Comprimido orodispersable multicapa | |
| ES2237121T3 (es) | Preparacion solida disgregable rapidamente. | |
| ES2399898T3 (es) | Composiciones farmacéuticas de sabor enmascarado preparadas por coacervación | |
| CA2322644C (en) | Pharmaceutical composition of topiramate | |
| RU2548748C2 (ru) | Композиции, включающие слабоосновные лекарственные вещества, и лекарственные формы с контролированным высвобождением | |
| ES2211215T3 (es) | Composicion de galantamina de liberacion controlada. | |
| ES2311500T3 (es) | Particulas farmaceuticas de sabor enmascarado. | |
| US8512744B2 (en) | Sustained release micropellets and process for producing the same | |
| ES2590807T3 (es) | Composición que comprende una mezcla de principios activos y procedimiento de preparación | |
| JP2006502156A (ja) | 風味を遮断された投与形態およびそれらの製剤の方法 | |
| KR100979328B1 (ko) | 코팅된 미립자 세푸록심 악세틸 조성물 | |
| KR20120031002A (ko) | 비-아편계 및 아편계 진통제의 조합을 포함하는 구강붕해정 조성물 | |
| JP2005527508A (ja) | 経口デリバリー用急速溶融多粒子製剤 | |
| US20130071476A1 (en) | Rapid Melt Controlled Release Taste-Masked Compositions | |
| JPH10502629A (ja) | 懸濁液中のモグイステインの制御放出のための薬剤組成物 | |
| WO2009106824A2 (en) | Pharmaceutical formulations | |
| MX2011007399A (es) | Suspension farmaceutica de liberacion doble. | |
| CN104274409A (zh) | 一种易于吞服的药物微球及其制备方法 | |
| JP2000191519A (ja) | 薬効成分の不快な官能的性質が隠蔽された速放性粒状物 | |
| JP5013871B2 (ja) | 経口徐放性医薬組成物 | |
| ZA200600159B (en) | Novel solid pharmaceutical composition comprising amisulpride | |
| JP2003055199A5 (https=) | ||
| ES2325599T3 (es) | Sistema de enmascaramiento del sabor para farmacos no plastificantes. | |
| JPWO2005011637A1 (ja) | 用時分散型製剤 | |
| CN114272233A (zh) | 一种奥司他韦组合物及其制备方法 |